SAN JOSE, CA. – March 14 2022 – Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, announced the healthcare findings of its global Enterprise Cloud Index (ECI) survey and research report, which measures enterprise progress with cloud adoption in the industry. The research showed that healthcare organizations appear to be in the early phases of cloud adoption and behind the cross-industry global respondent average. However, adoption is expected to jump from 27% to 51% in the next three years, in line with the global trend of evolving to a multicloud IT infrastructure that spans a mix of private and public clouds.
Multicloud is the dominant IT architecture in use worldwide, however, among healthcare ECI respondents, 30% say private cloud is their most common IT deployment model. The healthcare industry is highly regulated and has likely been slower to embrace the public cloud as a bonafide component of their IT environments for security and privacy reasons. While multicloud adoption is trending upwards, the complexity of managing across cloud borders remains a major challenge for healthcare organizations, with 92% of respondents agreeing that success requires simpler management across multicloud infrastructures. To address top challenges related to interoperability, security, cost and data integration, 90% agree that a hybrid multicloud model, an IT operating model with multiple clouds both private and public with interoperability between, is ideal.
“Multicloud is here to stay, but complexity and challenges remain as regulations drive many of healthcare organizations’ IT deployment decisions,” said Joseph Wolfgram, Healthcare CTO at Nutanix. “Regardless of where they are in their multicloud journeys, evolution to a hybrid multicloud IT infrastructure that spans a mix of private and public clouds with interoperability is underway and necessary for healthcare organizations to succeed.”
Healthcare survey respondents were asked about their current cloud challenges, how they’re running business applications now, and where they plan to run them in the future. Respondents were also asked about the impact of the pandemic on recent, current, and future IT infrastructure decisions and how IT strategy and priorities may change because of it. Key findings from this year’s report include:
For the fourth consecutive year, Vanson Bourne conducted research on behalf of Nutanix, surveying 1,700 IT decision-makers around the world in August and September 2021. This report is supplemental to the global Fourth Annual Enterprise Cloud Index master report and focuses on cloud deployment and planning trends in the healthcare industry, based on the responses of 250 IT professionals in that market. It highlights healthcare provider cloud plans, priorities, and experiences and includes comparisons of the healthcare industry’s multicloud activity with that of other markets and the global response base overall. The respondent base spanned various business sizes and the following geographies: the Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific Japan (APJ) region.
To learn more about the report and findings, please download the full fourth Nutanix Enterprise Cloud Index, here.
Nutanix is a global leader in cloud software and a pioneer in hyperconverged infrastructure solutions, making clouds invisible, freeing customers to focus on their business outcomes. Organizations around the world use Nutanix software to leverage a single platform to manage any app at any location for their hybrid multicloud environments. Learn more at www.nutanix.com or follow us on social media @nutanix.
© 2022 Nutanix, Inc. All rights reserved. Nutanix, the Nutanix logo, and all Nutanix product and service names mentioned herein are registered trademarks or trademarks of Nutanix, Inc. in the United States and other countries. Other brand names mentioned herein are for identification purposes only and may be the trademarks of their respective holder(s). This release may contain links to external websites that are not part of Nutanix.com. Nutanix does not control these sites and disclaims all responsibility for the content or accuracy of any external site. Our decision to link to an external site should not be considered an endorsement of any content on such a site. Certain information contained in this press release may relate to or be based on studies, publications, surveys and other data obtained from third-party sources and our own internal estimates and research. While we believe these third-party studies, publications, surveys and other data are reliable as of the date of this press release, they have not independently verified, and we make no representation as to the adequacy, fairness, accuracy, or completeness of any information obtained from third-party sources.
This release may contain express and implied forward-looking statements, which are not historical facts and are instead based on our current expectations, estimates and beliefs. The accuracy of such statements involves risks and uncertainties and depends upon future events, including those that may be beyond our control, and actual results may differ materially and adversely from those anticipated or implied by such statements. Any forward-looking statements included herein speak only as of the date hereof and, except as required by law, we assume no obligation to update or otherwise revise any of such forward-looking statements to reflect subsequent events or circumstances.